This guideline was developed before the COVID-19 pandemic. It covers diagnosing and managing pneumonia in adults who do not have COVID-19. It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment.
July 2022:...
Ewig, S;
Kolditz, M;
Pletz, M;
Atiner, A;
Albrich, W;
Drömann, D;
Flick, H;
Gatermann, S;
Krüger, S;
Nehls, W;
Witzenrath, M.
Die vorliegende Leitlinie umfasst ein aktualisiertes Konzept der Behandlung und Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die bisherige Leitlinie aus dem Jahre 2016 ab. Sie wurde entsprechend den Maßgaben zur Methodologie einer S3-Leitlinie erarbeitet und verabsch...
This guideline provides recommendations for the management of suspected and confirmed community- and hospital-acquired pneumonia in adults. However, it does not provide recommendations on areas of care where best practice is already established, such as diagnosis using chest X-ray. This guideline does no...
Tis part II of the guidelines for the diagnosis and management of critical illness-related corticosteroid insufciency (CIRCI) in critically ill patients is related to acute illnesses that may be complicated by CIRCI. We followed
strictly the same methodology as for part I (see Appendix 1 in Supplementary...
Torres, A;
Niederman, M. S;
Chastre, J;
Ewig, S;
Fernandez-Vandellos, P;
Hanberger, H;
Kollef, M;
Li Bassi, G;
Luna, C. M;
Martin-Loeches, I;
Paiva, J. A;
Read, R. C;
Rigau, D;
Timsit, J. F;
Welte, T;
Wunderink, R.
The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studi...
Cho, Young-Jae;
Cho, Young-Jae;
Moon, Jae Young;
Shin, Ein-Soon;
Kim, Je Hyeong;
Jung, Hoon;
Park, So Young;
Kim, Ho Cheol;
Sim, Yun Su;
Rhee, Chin Kook;
Lim, Jaemin;
Lee, Seok Jeong;
Lee, Won Yeon;
Lee, Hyun Jeong;
Kwak, Sang Hyun;
Kang, Eun Kyeong;
Chung, Kyung Soo;
Choi, Won-Il.
Since the first description of acute respiratory distress syndrome (ARDS) as a series of 12 patients in 1967 by Ashbaugh
et al.1
, it still remains a major public health problem that incurs
high health care costs and causes major mortality in the intensive care unit (ICU) despite improvements in outcomes...
The microbial causes of pneumonia vary according to its origin and the immune constitution of the patient. Pneumonia is classified into community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP) and pneumonia in the immunocompromised. The guideline development process is guided by its scope - ...
Dans le but d’accroître le nombre d’enfants ayant accès au traitement adapté, la classification et le guide thérapeutique simplifiés de l’OMS pour la prise en charge de la pneumonie de l’enfant dans les établissements de santé de premier niveau et les services de consultation ambulatoire o...
The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces oral c...
Pneumonia/drug therapy,
Anti-Bacterial Agents/administration & dosage,
Severity of Illness Index,
Health Facilities,
Amoxicillin/administration & dosage,
Gentamicins/administration & dosage,
Chloramphenicol/administration & dosage,
Ampicillin/administration & dosage,
Ceftriaxone/administration & dosage,
Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage
Se realizó el análisis de la priorización de la guía en conjunto con el MSPS. Para el análisis se aplicaron los instrumentos sugeridos por la Guía Metodológica. La priorización se basó en el peso de las diferentes situaciones en la morbimortalidad de los niños menores de 5 años (carga de enfer...
